Cargando…

Interruption and Non-Adherence to Long-Term Adjuvant Hormone Therapy Is Associated with Adverse Survival Outcome of Breast Cancer Women - An Asian Population-Based Study

This study aimed to evaluate the survival rate of women with breast cancer (BC) comparing persistence versus interruption and adherence versus non-adherence to adjuvant hormonal therapy (HT) in Asian population. Newly-diagnosed BC women from 2003 to 2010 were retrospectively identified from the Taiw...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hsieh, Kun-Pin, Chen, Li-Chia, Cheung, Kwok-Leung, Chang, Chao-Sung, Yang, Yi-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931619/ https://www.ncbi.nlm.nih.gov/pubmed/24586261 http://dx.doi.org/10.1371/journal.pone.0087027

Ejemplares similares

Investigating the effectiveness of adjuvant therapy for patients with hormone receptor-positive ductal carcinoma in situ
por: Tsai, Chi-Jui, et al.
Publicado: (2022)

Investigating the Impact of Immune-Related Adverse Events, Glucocorticoid Use and Immunotherapy Interruption on Long-Term Survival Outcomes
por: de la Bruyère, Charline Lafayolle, et al.
Publicado: (2021)

Importance of medication adherence in treatment needed diabetic retinopathy
por: Kao, Chia-Chen, et al.
Publicado: (2021)

Evaluation of Sarcopenia, Frailty, and Inflammation on Adverse Events and Survival Outcomes in Patients with Oral Cavity Squamous Cell Carcinoma under Adjuvant Chemoradiotherapy
por: Huang, Chun-Hou, et al.
Publicado: (2021)

Treatment Strategies and Survival Outcomes in Breast Cancer
por: Cheung, Kwok-Leung
Publicado: (2020)

Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer [Letter]
por: Bekele, Firomsa
Publicado: (2021)

Assessing Adherence to Adjuvant Hormone Therapy in Breast Cancer Patients in Routine Clinical Practice
por: Camejo, Natalia, et al.
Publicado: (2023)

Endocrine Therapy for Breast Cancer: A Model of Hormonal Manipulation
por: Johnston, Simon J., et al.
Publicado: (2018)

Adherence to Adjuvant Hormonal Therapy and Associated Factors Among Women with Breast Cancer [Response To Letter]
por: Wako, Zerko, et al.
Publicado: (2022)

Adjuvant radiotherapy and chemotherapy improve survival in patients with pancreatic adenocarcinoma receiving surgery: adjuvant chemotherapy alone is insufficient in the era of intensity modulation radiation therapy
por: Hsieh, Mao‐Chih, et al.
Publicado: (2018)

Investigation of Factors Affecting Adherence to Adjuvant Hormone Therapy in Early-Stage Breast Cancer Patients: A Comprehensive Systematic Review
por: Yang, Seongwoo, et al.
Publicado: (2023)

Barriers and facilitators of adjuvant hormone therapy adherence and persistence in women with breast cancer: a systematic review
por: Moon, Zoe, et al.
Publicado: (2017)

Adherence to Antiretroviral Therapy and Acceptability of Planned Treatment Interruptions in HIV-Infected Children
por: Harrison, Linda, et al.
Publicado: (2012)

Growth without growth hormone in combined pituitary hormone deficiency caused by pituitary stalk interruption syndrome
por: Lee, Sang Soo, et al.
Publicado: (2017)

3365 Treatment Interruptions and Early Discontinuation of Hormone Therapy in Hormone Receptor-Positive Breast Cancer Patients
por: Mao, Daqin, et al.
Publicado: (2019)

Proton pump inhibitors reduce the survival of advanced lung cancer patients with therapy of gefitinib or erlotinib
por: Lee, Chia-Han, et al.
Publicado: (2022)

Failure to complete adjuvant chemotherapy is associated with adverse survival in stage III colon cancer patients
por: Morris, M, et al.
Publicado: (2007)

The association between immune-related adverse events and survival outcomes in Asian patients with advanced melanoma receiving anti-PD-1 antibodies
por: Wu, Chiao-En, et al.
Publicado: (2020)

Interactions between Alcohol Consumption and Adjuvant Hormone Therapy in Relation to Breast Cancer-Free Survival
por: Kowalski, Allison, et al.
Publicado: (2018)

Healthcare Provider Perspectives on Adherence to Adjuvant Endocrine Therapy after Breast Cancer
por: Lambert, Leah K., et al.
Publicado: (2021)

Tamoxifen resistance and adjuvant hormone therapy
por: Howell, A
Publicado: (2005)

Adjuvant chemotherapy for patients with stage II high-risk and III colon cancer: Hindering factors to adherence and impact on long-term survival
por: Kim, Jieun, et al.
Publicado: (2021)

Predicting short-term interruptions of antiretroviral therapy from summary adherence data: Development and test of a probability model
por: Harris, Rebecca Arden, et al.
Publicado: (2018)

Increasing Adherence to Adjuvant Hormone Therapy Among Patients With Breast Cancer: A Smart Phone App-Based Pilot Study
por: Krok-Schoen, Jessica L., et al.
Publicado: (2019)

Breast Cancer Survivors’ Lived Experience of Adjuvant Hormone Therapy: A Thematic Analysis of Medication Side Effects and Their Impact on Adherence
por: Ibrar, Maryam, et al.
Publicado: (2022)

Evaluation of Probiotic Survivability in Yogurt Exposed To Cold Chain Interruption
por: Ferdousi, Rohollah, et al.
Publicado: (2013)

Feasibility of a polydioxanone plate as an adjuvant material in rhinoplasty in Asians
por: Oh, Gwang Jin, et al.
Publicado: (2019)

Disparities in Adverse Maternal Outcomes Among Asian Women in the US Delivering at Term
por: Wagner, Stephen M., et al.
Publicado: (2020)

Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer
por: Sardesai, Sagar, et al.
Publicado: (2020)

Interrupted aortic arch: A case report
por: Franconeri, Andrea, et al.
Publicado: (2020)

Association between hyperglycaemic crisis and long-term major adverse cardiovascular events: a nationwide population-based, propensity score-matched, cohort study
por: Chang, Li-Hsin, et al.
Publicado: (2016)

High Sustained Virologic Response Rates of Glecaprevir/Pibrentasvir in Patients With Dosing Interruption or Suboptimal Adherence
por: Zamor, Philippe J., et al.
Publicado: (2021)

Prevalence and Determinants of Adherence to Oral Adjuvant Endocrine Therapy among Breast Cancer Patients in Singapore
por: Ali, Eskinder Eshetu, et al.
Publicado: (2017)

Vitamin D in children with growth hormone deficiency due to pituitary stalk interruption syndrome
por: Delecroix, Cécile, et al.
Publicado: (2018)

Optimizing Adherence to Adjuvant Imatinib in Gastrointestinal Stromal Tumor
por: Tetzlaff, Eric D., et al.
Publicado: (2013)

Adherence to Adjuvant Endocrine Therapy in Breast Cancer Patients
por: Rosso, Roberta, et al.
Publicado: (2023)

Improving Adherence to Adjuvant Hormonal Therapy Among Disadvantaged Women Diagnosed with Breast Cancer in South Carolina: Proposal for a Multimethod Study
por: Felder, Tisha M, et al.
Publicado: (2020)

Impact of web application support versus standard management on adherence with adjuvant hormone therapy in patients treated for breast cancer: the WEBAPPAC study
por: Gernier, François, et al.
Publicado: (2023)

Controversies in hormonal adjuvant therapy for premenopausal patients
por: Howell, A
Publicado: (2009)

Controversies in the hormonal adjuvant therapy of postmenopausal patients
por: Dowsett, M
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sm50kdhbj2hbt2kdfkehmkvt7f